ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Vidpok1	5/9/2016 1:12:57 PM
	Read Replies (1) of 4474

Denner engineers a brilliant deal to maintain funding which should sustain operations until113 is launched. The detractors dream up a scenario "the truth" by which the company "passed" on acquiring all of Ariad. Based on what ? Based on someone's agenda to figure out some story to disparage the actual fact that Denner found a way to not only sustain operations, but also to lessen expenses plus adding a clause by which an acquiring company can reacquire Iclusig. Absolutely a great deal for Ariad and most of us here except the one. He should have posted this nonsense on the other board where some actually agree with this fluff.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next